Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vitali Pool

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Vaccine|September 13, 2005
Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)Lauren DiMiceli, Vitali Pool, John M Kelso, et al.
Vaccine|March 26, 2018
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USAVitali Pool, Antigona Tomovici, David R Johnson, et al.
The Journal of Infectious Diseases|August 27, 2014
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccineMichael D Decker, Phillip Hosbach, David R Johnson, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2004
A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001Weigong Zhou, Vitali Pool, Frank DeStefano, et al.
Clinical and Vaccine Immunology : CVI|September 19, 2014
Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of ageGary S Marshall, Vitali Pool, David P Greenberg, et al.
Vaccine|February 8, 2008
Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003Armenak Asatryan, Vitali Pool, Robert T Chen, et al.
Vaccine|September 14, 2020
Brand-specific rates of pertussis disease among Wisconsin children given 1-4 doses of pertussis Vaccine, 2010-2014James H Conway, Jeffrey P Davis, Jens C Eickhoff, et al.
Human Vaccines & Immunotherapeutics|July 9, 2016
Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccineRoger Baxter, John Hansen, Julius Timbol, et al.
Vaccine|July 5, 2016
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlersJohn Hansen, Julius Timbol, Ned Lewis, et al.
Drug Safety|October 9, 2008
Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting SystemsSoju Chang, Vitali Pool, Kathryn O'Connell, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Vaccine|September 13, 2005
Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)Lauren DiMiceli, Vitali Pool, John M Kelso, et al.
Vaccine|March 26, 2018
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USAVitali Pool, Antigona Tomovici, David R Johnson, et al.
The Journal of Infectious Diseases|August 27, 2014
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccineMichael D Decker, Phillip Hosbach, David R Johnson, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2004
A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001Weigong Zhou, Vitali Pool, Frank DeStefano, et al.
Clinical and Vaccine Immunology : CVI|September 19, 2014
Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of ageGary S Marshall, Vitali Pool, David P Greenberg, et al.
Vaccine|February 8, 2008
Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003Armenak Asatryan, Vitali Pool, Robert T Chen, et al.
Vaccine|September 14, 2020
Brand-specific rates of pertussis disease among Wisconsin children given 1-4 doses of pertussis Vaccine, 2010-2014James H Conway, Jeffrey P Davis, Jens C Eickhoff, et al.
Human Vaccines & Immunotherapeutics|July 9, 2016
Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccineRoger Baxter, John Hansen, Julius Timbol, et al.
Vaccine|July 5, 2016
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlersJohn Hansen, Julius Timbol, Ned Lewis, et al.
Drug Safety|October 9, 2008
Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting SystemsSoju Chang, Vitali Pool, Kathryn O'Connell, et al.
Pageof 3